Enifer has completed a 4-metric-ton production run of PEKILO Pet, marking the first time the ingredient is available in meaningful quantities for manufacturer formulation trials. Delivered as a dry ingredient compatible with standard storage and handling, PEKILO Pet is designed to integrate into existing wet and dry manufacturing processes.
"With this production run, we can move PEKILO Pet from the R&D lab to the factory floor, and perform formulation trials under actual conditions," said Jeroen Schweitz, chief commercial officer at Enifer. "We already know that PEKILO Pet performs well in both extrusion and retort systems. It provides to marketeers and developers a new ingredient that combines nutrition, sustainability, and enables differentiation in a demanding consumer market."
According to Enifer, the European pet food market continues to expand, with industry value in the tens of billions of euros and steady growth driven by premiumization and rising pet ownership. The ingredient sector, particularly protein inputs, is forecast to grow as manufacturers pursue differentiated, high-protein formulations and diet-specific products, including exclusion diet and hypoallergenic offerings. Supply chain resilience and ingredient reliability also remain central concerns as logistical pressures and shifting raw material availability influence production planning across the region.
"This production run provides manufacturers with access to meaningful volumes at a time when protein diversification, ingredient reliability and sustainability are top of mind," said Simo Ellilä, CEO of Enifer. "In a sea of novel proteins, PEKILO Pet offers flexibility in applications, ease of use, and consumer acceptability. We are working closely with manufacturers and brands as they integrate PEKILO Pet into their product portfolios."
